Status:
COMPLETED
A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects
Lead Sponsor:
Abbott
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of three different strengths of an investigational product dosed twice a day over 7 days in healthy subjects.
Eligibility Criteria
Inclusion
- Males and Females with a condition of general good health.
- Must be willing to participate in all study-related procedures.
Exclusion
- History of significant sensitivity to any drug.
- Allergy to soy lecithin, soybeans, soybean oil, or other soybean derivatives.
- A requirement for medications, vitamins and/or herbal supplements during the study.
- Pregnant or breast-feeding.
- History of drug or alcohol abuse.
- Positive Hepatitis or HIV test.
- History of certain medical conditions or any uncontrolled medical illness.
- History of certain gastrointestinal surgeries that may interfere with gastrointestinal motility, PH or absorption.
- Current participation in another clinical study or receipt of investigational drug within the past 6 weeks.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00854659
Start Date
March 1 2009
Last Update
November 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 18101
Austin, Texas, United States, 78744